Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H2218 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	1 of 1
2	2	HOUSE DOCKET, NO. 3273 FILED ON: 1/20/2023
3	3	HOUSE . . . . . . . . . . . . . . . No. 2218
4	4	The Commonwealth of Massachusetts
5	5	_________________
6	6	PRESENTED BY:
7	7	Kay Khan
8	8	_________________
9	9	To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
10	10	Court assembled:
11	11	The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
12	12	An Act relative to newborn screenings for congenital cytomegalovirus.
13	13	_______________
14	14	PETITION OF:
15	15	NAME:DISTRICT/ADDRESS :DATE ADDED:Kay Khan11th Middlesex1/17/2023Colleen M. Garry36th Middlesex2/8/2023Brian M. Ashe2nd Hampden2/9/2023Hannah Kane11th Worcester2/10/2023Samantha Montaño15th Suffolk2/13/2023Jack Patrick Lewis7th Middlesex2/13/2023Lindsay N. Sabadosa1st Hampshire2/14/2023David Henry Argosky LeBoeuf17th Worcester2/15/2023Ryan C. FattmanWorcester and Hampden2/16/2023Brian W. Murray10th Worcester2/16/2023Smitty Pignatelli3rd Berkshire2/22/2023Paul K. Frost7th Worcester2/24/2023Patrick M. O'ConnorFirst Plymouth and Norfolk3/1/2023Joseph D. McKenna18th Worcester3/6/2023Judith A. Garcia11th Suffolk3/10/2023Adrian C. Madaro1st Suffolk3/13/2023William C. Galvin6th Norfolk3/14/2023 1 of 5
16	16	HOUSE DOCKET, NO. 3273 FILED ON: 1/20/2023
17	17	HOUSE . . . . . . . . . . . . . . . No. 2218
18	18	By Representative Khan of Newton, a petition (accompanied by bill, House, No. 2218) of Kay
19	19	Khan and others relative to newborn screenings for congenital cytomegalovirus. Public Health.
20	20	[SIMILAR MATTER FILED IN PREVIOUS SESSION
21	21	SEE HOUSE, NO. 2338 OF 2021-2022.]
22	22	The Commonwealth of Massachusetts
23	23	_______________
24	24	In the One Hundred and Ninety-Third General Court
25	25	(2023-2024)
26	26	_______________
27	27	An Act relative to newborn screenings for congenital cytomegalovirus.
28	28	Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
29	29	of the same, as follows:
30	30	1 Chapter 111 of the General Laws is hereby amended by inserting after section 110C the
31	31	2following sections:-
32	32	3 Section 110D: Required Newborn Screening for Congenital Cytomegalovirus
33	33	4 For the purposes of this section, the following words shall, unless the context clearly
34	34	5requires otherwise, have the following meanings:-
35	35	6 “Birthing facility”, an inpatient or ambulatory health care facility licensed by the
36	36	7department of public health that provides birthing and newborn care services. 2 of 5
37	37	8 “Congenital Cytomegalovirus (hereinafter referred to as cCMV) screening”, the
38	38	9identification of a newborn who may have congenital CMV infection or has cCMV confirmed
39	39	10through the use of a saliva or urine test.
40	40	11 “Department”, the department of public health.
41	41	12 “Newborn,” any liveborn infant who has not yet attained the age of 21 days from a birth
42	42	13occurring in the commonwealth or from a birth prior to transfer to a hospital in the
43	43	14commonwealth.
44	44	15 The department, in consultation with the perinatal advisory committee, shall develop
45	45	16regulations for all hospitals and birthing facilities requiring cCMV screening within one year of
46	46	17the passage of this legislation. These regulations shall consider evidence-based guidance.
47	47	18 The cCMV screening shall be performed using a saliva PCR test unless one is
48	48	19unavailable in which case a urine PCR test may be used. If positive, a saliva PCR test would
49	49	20require a confirmatory urine PCR test. The department may approve another test to conduct
50	50	21cCMV screening; provided, however, that the test shall be, at the discretion of the department, at
51	51	22least as accurate, widely available and cost-effective as a saliva or urine PCR test. A screening
52	52	23shall be performed within 21 days from the date of birth and before the newborn infant is
53	53	24discharged from the birthing facility to the care of the parent or guardian; provided, however,
54	54	25that the screening shall not be performed if the parent or guardian of the newborn infant objects
55	55	26to the screening based upon a sincerely held religious belief of the parent or guardian. The
56	56	27cCMV educational materials outlined in section 70I(b) shall be provided to the parent or
57	57	28guardian of the infant at the time of cCMV screening. 3 of 5
58	58	29 A hospital that provides birthing and newborn services or a birthing facility shall adopt
59	59	30protocols for cCMV screening using a saliva or urine PCR test or another test approved by the
60	60	31department under this section for all newborns prior to discharge, and not to exceed 21 days from
61	61	32the date of birth, based on the department’s regulations, on or before January 1, 2025.
62	62	33 The cost of providing the newborn cCMV screening shall be a covered benefit
63	63	34reimbursable by all health insurers, except for supplemental policies that only provide coverage
64	64	35for specific diseases, hospital indemnity, Medicare supplement or other supplemental policies. In
65	65	36the absence of a third-party payer, the charges for the newborn cCMV screening shall be paid by
66	66	37the Commonwealth.
67	67	38 A hospital or birthing facility shall report annually to the department data including, but
68	68	39not limited to, the number of cCMV tests administered and the outcomes of said tests. The
69	69	40hospital or birthing facility shall inform, orally and in writing, a parent or guardian of the
70	70	41newborn infant the result of the cCMV screening test regardless of its outcome. This information
71	71	42shall also be provided in writing to the newborn infant's primary care physician and to the
72	72	43department through its electronic birth certificate system or such mechanism as specified by the
73	73	44department.
74	74	45 The department shall review the protocols required under this section and the
75	75	46implementation of these protocols as part of its birthing facility licensure review processes.
76	76	47 The department shall promulgate regulations to implement the cCMV screening program.
77	77	48 Nothing in this statute shall preclude newborns born at home from obtaining said cCMV
78	78	49screening. 4 of 5
79	79	50 Section 110E: Advisory Committee for CMV Screening Program
80	80	51 There is hereby established an advisory committee for the purpose of implementing the
81	81	52provisions of Section 110D. The advisory committee shall consist of the following members to
82	82	53be appointed by the commissioner of the department: a representative of the hospital industry; a
83	83	54primary care pediatrician or family practitioner; an otolaryngologist; a neonatologist; an
84	84	55infectious disease specialist; a clinician representing newborn nurseries; an audiologist; an
85	85	56ophthalmologist; an obstetrician-gynecologist; a representative of the commonwealth's early
86	86	57intervention program; 2 parents and/or guardians of a child impacted by cCMV; 2 medical
87	87	58professionals; a developer of preventative and/or therapeutic interventions for cCMV; a teacher
88	88	59of the deaf; and a representative of the department.
89	89	60 The advisory committee shall advise the department regarding the validity and cost of
90	90	61proposed cCMV regulations and/or cCMV screening, and shall recommend standards for
91	91	62performing and interpreting screening tests based on the most current technological methods, for
92	92	63documenting test results and follow-up, and for facilitating interaction between professionals and
93	93	64agencies that participate in follow-up care. Members of the advisory committee shall serve
94	94	65without compensation. The advisory committee shall be provided support services by the
95	95	66department.
96	96	67 Chapter 111 of the General Laws is hereby further amended by inserting after Section
97	97	6870H the following section:-
98	98	69 Section 70I: Congenital cytomegalovirus; public information program; annual report
99	99	70 (a) The commissioner of the department shall establish, promote, and maintain a public
100	100	71information program regarding congenital cytomegalovirus, hereinafter referred to as cCMV. 5 of 5
101	101	72Such program shall be conducted throughout the commonwealth, and under said program, a
102	102	73hospital or birthing facility as defined in section 70E or any healthcare provider, physician
103	103	74assistant, nurse or midwife who renders prenatal or postnatal care shall give expectant or new
104	104	75parents or guardians information provided by the department under subsection (b). Such
105	105	76information shall be made available at the first prenatal appointment or at a preconception visit if
106	106	77applicable, whichever is earliest.
107	107	78 (b) The department shall make available to any healthcare provider, physician assistant,
108	108	79nurse or midwife who renders prenatal or postnatal care or offers fertility counseling or care to a
109	109	80parent or guardian the following: (i) up-to-date evidence-based, written information about cCMV
110	110	81and universal cCMV screening that has been vetted by an appropriate group of medical experts
111	111	82as determined by the department in conjunction with the advisory committee as established in
112	112	83section 110E of said Chapter 111; provided, however, that the written information provided shall
113	113	84include preventative measures that can be taken throughout pregnancy, and (ii) contact or other
114	114	85referral information for additional educational and support resources. The department may also
115	115	86make such information available to any other person who seeks information about cCMV
116	116	87infections.